Vimian Group AB (publ)

Stockholm Stock Exchange:VIMIAN.ST

Sector

🏥 Health Care

Industries

🧬 Biotechnology

🔬 Clinical Trials

🍔 Meat

💊 Pharmaceuticals

💻 Telehealth

Location

Sweden

Market Cap

USD 2.16 B

Share Price

USD 4.15

Avg Daily Volume

446,769

Change (1 day)

0.75%

Change (1 year)

27.26%

Change (YTD)

15.46%

Vimian Group AB (publ) Free Cash Flow Per Share for the year ending December 31, 2024: USD 0.09

Vimian Group AB (publ) Free Cash Flow Per Share is USD 0.09 for the year ending December 31, 2024, a -192.50% change year over year. Free cash flow per share is the free cash flow generated per share. Indicates investment potential based on cash flow generation.

Vimian Group AB (publ) Free Cash Flow Per Share for the year ending December 31, 2023 was USD -0.10, a -344.92% change year over year.
Vimian Group AB (publ) Free Cash Flow Per Share for the year ending December 31, 2022 was USD 0.04, a 170.75% change year over year.
Vimian Group AB (publ) Free Cash Flow Per Share for the year ending December 31, 2021 was USD 0.01, a -137.69% change year over year.
Vimian Group AB (publ) Free Cash Flow Per Share for the year ending December 31, 2020 was USD -0.04, a -2,997.90% change year over year.

Quarterly
Annual
TTM

From:

To:

Zoom:

Key data

Date	Free Cash Flow Per Share	Dividend Per Share	Debt to Equity Ratio	Quick Ratio

Stockholm Stock Exchange: VIMIAN.ST

Vimian Group AB (publ)

CEO	Mr. Patrik Eriksson
IPO Date	June 18, 2021
Location	Sweden
Headquarters	Riddargatan 19
Employees	1,200
Sector	🏥 Health Care
Industries Biotechnology 🔬 Clinical Trials 🍔 Meat 💊 Pharmaceuticals 💻 Telehealth

Description

Vimian Group AB (publ) engages in the animal health business worldwide. It operates through Specialty Pharma, MedTech, Diagnostics, and Veterinary Services segments. The company offers proprietary diagnostics, prescription, and non-prescription treatments for preventive care and treatment of chronic conditions for companion animals under the Nextmune brand name; and molecular and immunodiagnostic solutions that are used by laboratories for veterinary specific applications with a focus on livestock and companion animal health markets under the Indical Bioscience brand name. It also provides procurement and tech-driven operations, such as online marketing, and education and HR, as well as a community for veterinary clinics through a membership-based platform under the VetFamily brand name; and orthopedic implants for veterinarians and universities under the Movora brand name. The company was incorporated in 2020 and is headquartered in Stockholm, Sweden.